Related Experiment Video
Updated: Apr 26, 2026
Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma
V R Lo Vasco1, M Leopizzi, C Puggioni
1Sense Organs Department, Policlinico Umberto I Faculty of Medicine and Dentistry, Sapienza University of Rome, viale del Policlinico 155, 00185, Italy, Rome, ritalovasco@hotmail.it.
Abstract:
Ezrin, a protein belonging to the Ezrin, radixin and moesin (ERM) family, was engaged in the metastatic spread of osteosarcoma. The Protein 4.1, Ezrin, radixin, moesin (FERM) domain of Ezrin binds the membrane Phosphatydil inositol (4,5) bisphosphate (PIP2), a crucial molecule belonging to the Phosphoinositide (PI) signal transduction pathway. The cytoskeleton cross-linker function of Ezrin largely depends on membrane PIP2 levels, and thus upon the activity of related enzymes belonging to the PI-specific phospholipase C (PI-PLC) family. Based on the role of Ezrin in tumour progression and metastasis, we silenced the expression of Vil2 (OMIM *123900), the gene which codifies for Ezrin, in cultured human osteosarcoma 143B and Hs888 cell lines. After Ezrin silencing, the growth rate of both cell lines was significantly reduced and morphogical changes were observed. We also observed moderate variations both of selected PI-PLC enzymes within the cell and of expression of the corresponding PLC genes. In 143B cell line the transcription of PLCB1 decreased, of PLCG2 increased and of PLCE differed in a time-dependent manner. In Hs888, the expression of PLCB1 and of PLCD4 significantly increased, of PLCE moderately increased in a time dependent manner; the expression of PLCG2 was up-regulated. These observations indicate that Ezrin silencing affects the transcription of selected PLC genes, suggesting that Ezrin might influence the expression regulation of PI-PLC enzymes.
Insights
Silencing ezrin, a protein involved in osteosarcoma metastasis, reduced cell growth and altered the expression of PI-specific phospholipase C (PI-PLC) genes. This suggests ezrin influences PI-PLC enzyme regulation, impacting tumor progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Ezrin, an ERM protein, plays a role in osteosarcoma metastasis.
- Ezrin's FERM domain binds PIP2, crucial for the PI signaling pathway.
- Ezrin's function as a cytoskeleton cross-linker depends on PIP2 levels and PI-PLC activity.
Purpose of the Study:
- To investigate the effect of ezrin silencing on osteosarcoma cell lines.
- To determine if ezrin influences the expression of PI-PLC enzymes.
Main Methods:
- Ezrin expression was silenced in human osteosarcoma 143B and Hs888 cell lines using Vil2 gene silencing.
- Cell growth rates and morphology were assessed post-silencing.
- Expression levels of selected PI-PLC enzymes and their corresponding genes were analyzed.
Main Results:
- Ezrin silencing significantly reduced the growth rate and induced morphological changes in both cell lines.
- Moderate variations in PI-PLC enzyme levels and gene expression were observed.
- Specific changes in PLCB1, PLCG2, PLCE, and PLCD4 gene transcription were noted in a cell-line and time-dependent manner.
Conclusions:
- Ezrin silencing impacts the transcription of specific PI-PLC genes in osteosarcoma cells.
- Ezrin may play a regulatory role in the expression of PI-PLC enzymes.
- These findings suggest a potential therapeutic target for osteosarcoma metastasis.
Related Concept Videos
01:42Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:22PI3K/mTOR/AKT Signaling Pathway
01:22Amplifying Signals via Enzymatic Cascade